IA
NBRV

IFP Advisors’s Nabriva Therapeutics plc Ordinary Shares Ireland NBRV Stock Holding History

IFP Advisors’s Portfolio NBRV Stock Details NBRV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-28
Closed -$1K – 4680
2022
Q4 		$1K Sell
28
-672
-96% -$1.48K ﹤0.01% 4575
2022
Q3 		$1K Buy
700
+672
+2,400% +$2.83K ﹤0.01% 4764
2022
Q2 		$1K Hold
28
– – ﹤0.01% 4531
2022
Q1 		$1K Buy
+28
New +$340 ﹤0.01% 4529
2021
Q3 		– Hold
0
– – – 5187
2021
Q2 		– Hold
0
– – – 4962
2021
Q1 		– Hold
0
– – – 4792
2020
Q4 		– Hold
0
– – – 4538
2020
Q3 		– Hold
0
– – – 4346
2020
Q2 		– Hold
0
– – – 4123
2020
Q1 		– Hold
0
– – – 4013
2019
Q4 		– Sell
-1
Closed -$459 – 3900
2019
Q3 		$1K Buy
+1
New +$564 ﹤0.01% 2986

Other funds holding NBRV

VFA
Values First Advisors Gray, Tennessee $192M AUM 24.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $501B AUM 22.01% 1-Year Est. Return